×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Marker Therapeutics Inc. (MRKR) NASDAQ

$4.16 0.14 (3.60%)

Market Cap: $37.15M

As of 06/14/24 04:00 PM EDT. Market closed.

(MRKR)

Marker Therapeutics Inc. (MRKR)
NASDAQ

$4.16
0.14 (3.60%)

Market Cap: $37.15M

As of 06/14/24 04:00 PM EDT. Market closed.

Add to Portfolio

tapimmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. the company’s next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Peter Hoang
Full Time Employees
11,800
CEO Compensation (Base)
$362,500
CEO Compensation (Total)
$13.01M
URL
Address
5 W Forsyth St Ste 200, Florida, Jacksonville, 32202-3676.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Peter Hoang
Full Time Employees
11,800
CEO Compensation (Base)
$362,500
CEO Compensation (Total)
$13.01M
Address
5 W Forsyth St Ste 200, Florida, Jacksonville, 32202-3676.
PRICE CHART FOR MARKER THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$4.02
Days Range
$4.02 - $4.10
52 week range
$2.40 - $9.68
Volume
3,146
Avg. Volume (30 days)
16,686
Market Cap
$37.15M
Dividend Yield
-
P/E
-
Shares Outstanding
8,919,095
Open
-
Previous Close
$4.02
Days Range
$4.02 - $4.10
52 week range
$2.40 - $9.68
Volume
3,146
Avg. Volume (30 days)
16,686
Market Cap
$37.15M
Dividend Yield
-
P/E
-
Shares Outstanding
8,919,095
FINANCIAL STATEMENTS FOR MARKER THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MARKER THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Eansor Norman DavidDirectorMar 16, 2021 Buy$17.5014,285249,98816,713Jun 08, 2023, 09:35 PM
Hoang Peter L.President and CEOMar 24, 2022 Option Exercise$0.4848,37623,453483,286Mar 28, 2022, 09:06 PM
Vera JuanChief Scientific Officer & COOMar 24, 2022 Option Exercise$0.4833,46516,2242,671,845Mar 28, 2022, 09:04 PM
Kim Anthony H.Chief Financial OfficerMar 24, 2022 Option Exercise$0.4836,07617,490114,436Mar 28, 2022, 09:03 PM
Walker Paul Edward10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:18 PM
Sonsini Peter W.10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:17 PM
SANDELL SCOTT D10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:17 PM
MAKOWER JOSHUA10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:16 PM
Makhzoumi Mohamad10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:15 PM
Florence Anthony A. Jr.10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:14 PM
Chang Carmen10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:12 PM
Behbahani Ali10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:11 PM
BASKETT FOREST10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:09 PM
New Enterprise Associates 16, L.P.10% OwnerMar 16, 2021 Buy$1.755,714,2859,999,99910,714,285Mar 18, 2021, 05:08 PM
Wilson John RobertDirectorMar 16, 2021 Buy$1.751,714,2852,999,9997,799,350Mar 18, 2021, 04:39 PM
Vera JuanChief Development OfficerMar 16, 2021 Buy$1.75571,428999,9992,564,487Mar 18, 2021, 04:38 PM
Hoang Peter L.President and CEOMar 16, 2021 Buy$1.75142,857250,000332,568Mar 18, 2021, 04:36 PM
ELMS STEVEDirectorMar 16, 2021 Buy$1.751,142,8572,000,0003,142,857Mar 18, 2021, 04:35 PM
Eastern Capital LTD10% OwnerFeb 18, 2020 Option Exercise$1.20416,667500,0004,050,001Feb 20, 2020, 04:50 PM
Hoang Peter L.President and CEOAug 14, 2019 Buy$4.6210,00046,200189,711Aug 15, 2019, 04:33 PM
Eastern Capital LTD10% OwnerMay 14, 2018 Buy$2.401,300,0003,120,0005,300,002May 16, 2018, 05:28 PM
WILSON GLYNNDirectorSep 22, 2017 Option Exercise$3.18100,000318,000185,567Sep 26, 2017, 04:05 PM
WILSON GLYNNDirectorSep 22, 2017 Option Exercise$3.1827,35086,973158,217Sep 26, 2017, 04:05 PM
Hoang Peter L.CEO and PresidentSep 22, 2017 Option Exercise$3.18250,000795,000250,000Sep 25, 2017, 03:11 PM
Hoang Peter L.CEO and PresidentSep 22, 2017 Option Exercise$3.1870,289223,519179,711Sep 25, 2017, 03:11 PM
BONFIGLIO JOHN NPresident and COODec 12, 2016 Option Exercise$1.7410,41718,12631,251Dec 14, 2016, 04:31 PM
Eastern Capital LTD10% OwnerAug 10, 2016 Option Exercise$0.505,000,0002,500,00025,000,000Aug 12, 2016, 04:40 PM
WILSON GLYNNDirectorNov 12, 2015 Option Exercise$0.61315,000190,575960,457Nov 16, 2015, 05:06 PM
WILSON GLYNNDirectorNov 12, 2015 Option Exercise$0.6186,78252,503873,675Nov 16, 2015, 05:06 PM
Grisewood SherryDirectorFeb 26, 2014 Option Exercise$0.8028,12522,50028,330Nov 13, 2015, 05:28 PM
Reddish MarkDirectorFeb 26, 2014 Option Exercise$0.80225,000180,000226,667Nov 13, 2015, 05:04 PM
WILSON GLYNNDirectorDec 02, 2014 Option Exercise$1.00120,000120,000645,457Nov 13, 2015, 04:58 PM
WILSON GLYNNDirectorFeb 26, 2014 Option Exercise$0.80513,319410,655525,457Nov 13, 2015, 04:58 PM
Eastern Capital LTD10% OwnerSep 09, 2015 Option Exercise$0.2010,000,0002,000,00020,000,000Sep 11, 2015, 04:16 PM
Eastern Capital LTD10% OwnerJun 16, 2015 Option Exercise$0.505,000,0002,500,00010,000,000Jun 18, 2015, 11:33 AM
WILSON GLYNNCEOFeb 17, 2012 Option Exercise$0.15166,66725,0001,213,726Apr 24, 2012, 12:46 PM
CORIN DENISPresidentFeb 17, 2012 Option Exercise$0.15166,66725,0002,394,535Apr 20, 2012, 05:55 PM
WILSON GLYNNChairman and CEOMar 23, 2011 Option Exercise$0.17147,05925,0001,047,059Apr 05, 2011, 05:02 PM
CORIN DENISPresident and CFOMar 23, 2011 Option Exercise$0.17294,11850,0002,227,868Apr 05, 2011, 04:45 PM
CORIN DENISPresident and CFOMar 23, 2011 Sale$0.12160,00019,200135,300Apr 05, 2011, 04:45 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Eansor Norman DavidDirector03/16/2021249,988
Hoang Peter L.President and CEO03/24/202223,453
Vera JuanChief Scientific Officer & COO03/24/202216,224
Kim Anthony H.Chief Financial Officer03/24/202217,490
Walker Paul Edward10% Owner03/16/20219,999,999
Sonsini Peter W.10% Owner03/16/20219,999,999
SANDELL SCOTT D10% Owner03/16/20219,999,999
MAKOWER JOSHUA10% Owner03/16/20219,999,999
Makhzoumi Mohamad10% Owner03/16/20219,999,999
Florence Anthony A. Jr.10% Owner03/16/20219,999,999
Chang Carmen10% Owner03/16/20219,999,999
Behbahani Ali10% Owner03/16/20219,999,999
BASKETT FOREST10% Owner03/16/20219,999,999
New Enterprise Associates 16, L.P.10% Owner03/16/20219,999,999
Wilson John RobertDirector03/16/20212,999,999
Vera JuanChief Development Officer03/16/2021999,999
Hoang Peter L.President and CEO03/16/2021250,000
ELMS STEVEDirector03/16/20212,000,000
Eastern Capital LTD10% Owner02/18/2020500,000
Hoang Peter L.President and CEO08/14/201946,200
Eastern Capital LTD10% Owner05/14/20183,120,000
WILSON GLYNNDirector09/22/2017318,000
WILSON GLYNNDirector09/22/201786,973
Hoang Peter L.CEO and President09/22/2017795,000
Hoang Peter L.CEO and President09/22/2017223,519
BONFIGLIO JOHN NPresident and COO12/12/201618,126
Eastern Capital LTD10% Owner08/10/20162,500,000
WILSON GLYNNDirector11/12/2015190,575
WILSON GLYNNDirector11/12/201552,503
Grisewood SherryDirector02/26/201422,500
Reddish MarkDirector02/26/2014180,000
WILSON GLYNNDirector12/02/2014120,000
WILSON GLYNNDirector02/26/2014410,655
Eastern Capital LTD10% Owner09/09/20152,000,000
Eastern Capital LTD10% Owner06/16/20152,500,000
WILSON GLYNNCEO02/17/201225,000
CORIN DENISPresident02/17/201225,000
WILSON GLYNNChairman and CEO03/23/201125,000
CORIN DENISPresident and CFO03/23/201150,000
CORIN DENISPresident and CFO03/23/201119,200
Load More Insider Transactions
FUNDS WITH A POSITION IN MARKER THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC67,0530.00003%11.67%Other
RENAISSANCE TECHNOLOGIES LLC37,2500.00025%-0.8%Other
BLACKROCK INC.9920%-27.27%Other
CHANGE IN SHARES OUTSTANDING FOR MARKER THERAPEUTICS INC
STOCK BUYBACKS FOR MARKER THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
1.92%
1Q
03/31/2024
09/30/2023
0.86%
2Q
03/31/2024
06/30/2023
1.17%
3Q
03/31/2024
03/31/2023
2.07%
4Q
03/31/2024
12/31/2022
6.31%
5Q
03/31/2024
09/30/2022
6.48%
6Q
03/31/2024
06/30/2022
6.49%
7Q
03/31/2024
03/31/2022
7.11%
8Q
03/31/2024
12/31/2021
7.06%
9Q
03/31/2024
09/30/2021
7.15%
10Q
03/31/2024
06/30/2021
7.21%
11Q
03/31/2024
03/31/2021
57.64%
12Q
03/31/2024
12/31/2020
83.05%
13Q
03/31/2024
09/30/2020
89.94%
14Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
1.92%
1Q
09/30/2023
0.86%
2Q
06/30/2023
1.17%
3Q
03/31/2023
2.07%
4Q
12/31/2022
6.31%
5Q
09/30/2022
6.48%
6Q
06/30/2022
6.49%
7Q
03/31/2022
7.11%
8Q
12/31/2021
7.06%
9Q
09/30/2021
7.15%
10Q
06/30/2021
7.21%
11Q
03/31/2021
57.64%
12Q
12/31/2020
83.05%
13Q
09/30/2020
89.94%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MARKER THERAPEUTICS INC
LOADING...